)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Red Light Holland
Red Light Holland (TRIP) investor relations material
Red Light Holland Q1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2027 earnings summary31 Aug, 2026
Executive summary
Completed acquisition of Filament Health Corp. in Q1 2027, transforming the business into a focused life sciences platform centered on naturally derived psychedelic medicines.
Strategic shift to pharmaceutical R&D, GMP manufacturing, regulatory, and clinical supply capabilities, with a focus on psilocybin (PEX010) and ibogaine (IBEX011) drug candidates.
Emphasis on leveraging Filament’s expertise to expand regulated clinical and research supply opportunities and develop additional botanical drug candidates.
Financial highlights
Revenue was $0.186M in Q1 2027, down from $0.553M in Q1 2026.
Gross profit increased to $0.170M in Q1 2027 from $0.151M in Q1 2026.
Net loss widened to $1.889M in Q1 2027 from $1.046M in Q1 2026.
Adjusted EBITDA loss was $1.063M in Q1 2027 versus $0.679M in Q1 2026.
Cash and cash equivalents stood at $2.598M, with $5.017M in short-term investments as of June 30, 2026.
Outlook and guidance
Plans to advance PEX010 clinical and research supply programs and deepen relationships with academic and clinical institutions.
Intends to leverage pharmaceutical capabilities and IP to pursue additional naturally derived drug candidates and commercial opportunities.
Focus on disciplined capital allocation and execution to drive long-term value creation.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Red Light Holland
- Filament acquisition and rebrand drive focus on psychedelic drug innovation amid revenue decline.TRIP
Q4 2026 - Q3 2026 revenue up 8.3% year-over-year, with R&D focus and asset sales amid industry shifts.TRIPQ3 2026
- Revenue and profit fell sharply, but strong cash and R&D focus support future growth.TRIPQ2 2026
- Revenue declined and losses widened, but strategic expansion and innovation continued.TRIPQ1 2026
- Revenue up 4.05%, adjusted EBITDA loss down 23.54%, with strategic R&D and retail expansion.TRIPQ4 2025
Next Red Light Holland earnings date
Q2 202727 Nov, 2026
Red Light Holland
Next Red Light Holland earnings date
Q2 202727 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)